Induction of adenocarcinoma from hamster pancreatic islet cells treated with N-nitrosobis(2-oxopropyl)amine in vitro

Carcinogenesis

Volumn 20, Issue 2, 1999, Pages 317-324

  Schmied, B ^a,b   Liu, G ^a   Moyer, M P ^c   Hernberg, I S B ^a,d   Sanger, W ^e   Batra, S ^a,f   Pour, Parviz M ^a,f  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; CANCER GROWTH FACTOR; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LAMININ; LECTIN; PHYTOHEMAGGLUTININ; TRYPSIN INHIBITOR; VIMENTIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CODON; GENE MUTATION; HAMSTER; MALE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TOMATO;

ADENOMA, ISLET CELL; ANIMALS; CARCINOGENS; CELL DIVISION; CELL LINE; CRICETINAE; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; KARYOTYPING; MALE; MESOCRICETUS; NITROSAMINES; PANCREATIC NEOPLASMS;

EID: 0032963708     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.2.317     Document Type: Article

References (46)

1. Flaks, B., Moore, M.A. and Flaks, A. (1980) Ultrastructural analysis of pancreatic carcinogenesis. III. Multifocal cystic lesions induced by N-nitroso-bis(2-hydroxypropyl)amine in the hamster exocrine pancreas. Carcinogenesis, 1, 693-706.
2. Pour, P.M. (1984) Histogenesis of exocrine pancreatic cancer in the hamster model. Environ. Health Perspect., 56, 229-243.
3. Pour, P.M. (1988) Mechanism of pseudoductular (tubular) formation during pancreatic carcinogenesis in the hamster model. Am. J. Pathol., 130, 335-344.
4. Pour, P.M. and Wilson, R. (1980) Experimental pancreas tumor. In Moossa, A.R. (ed.) Cancer of the Pancreas. Williams and Wilkins, Baltimore, MD, pp. 37-158.
5. Pour, P.M. (1980) Experimental pancreatic ductal (ductular) tumors. In Fitzgerald, P.J. and Morrison, A.B. (eds) The Pancreas. William and Wilkins, Baltimore, MD, pp. 111-139.
6. Pour, P.M., Runge, R.G., Birt, D., Gingell, R., Lawson, T., Nagel, D., Wallcave, L. and Salmasi, S.Z. (1981) Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer, 47, 1573-1589.
7. Pour, P.M. (1981) The endocrine-exocrine pancreas: its clinical and morphological aspects and hyperplastic and neoplastic patterns. In Nagasawa, H. and Abe, K. (eds) Hormone Related Tumors. Japan Scientific Societies Press, Tokyo, Japan, pp. 103-120.
8. Pour, P.M. (1978) Islet cells as a component of pancreatic ductal neoplasms. I. Experimental study. Ductular cells, including islet cell precursors, and primary progenitor cells of tumors. Am. J. Pathol., 90, 295-316.
9. Pour, P.M., Weide, L., Liu, G., Kazakoff, K., Scheetz, M., Toshkov, I. and Sanger, W. (1997) Langerhans islets are the origin of ductal-type adenocarcinoma. In Malfertheiner, P. et al. (eds) Diagnostic Procedures in Pancreatic Disease, Springer Verlag, Heidelberg, Germany, pp. 331-339.
10. Pour, P.M., Weide, L. Liu, G., Kazakoff, K., Scheetz, M., Toshkov, I. Ikematsu, I., Fienhold, M.A. and Sanger, W. (1997) Experimental evidence for the origin of ductal type adenocarcinoma from the islets of Langerhans. Am. J. Pathol., 150, 2167-2180.
11. Fienhold, M.A., Kazakoff, K. and Pour, P.M. (1997) The effect of Streptozotocin and high-fat diet on BOP-induced tumors in the pancreas and in the submandibular gland of hamsters bearing transplants of homologous islets. Cancer Lett., 117, 155-160.
12. Bell, R.H., Sayers, H.J., Pour, P.M., Ray, M.B. and McCullough, P.J. (1989) Importance of diabetes in inhibition of pancreatic cancer by Streptozotocin. J. Surg. Res., 46, 515-519.
13. Bell, R.H., McCullough, P.J. and Pour, P.M. (19880 Influence of diabetes on susceptibility to experimental pancreatic cancer. Am. J. Surg., 155, 159-164.
14. Pour, P.M., Kazakoff, K. and Carlson, K. (1990) Inhibition of Streplozotocin-induced islet cell tumors and BOP-induced exogenous pancreatic tumors in Syrian hamsters. Cancer Res., 50, 1634-1639.
15. Bell, R.H. and Pour, P.M. (1987) Induction of pancreatic tumors in genetically non-diabetic but not in diabetic Chinese hamsters. Cancer Lett., 34, 221-230.
16. Pour, P.M. and Kazakoff, K. (1996) Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model. Am. J. Pathol., 149, 1017-1025.
17. Pour, P.M. and Morohoshi, T. (1994) Ductal adenocarcinoma. In Atlas of Exocrine Pancreatic Tumors. Morphology, Biology and Diagnosis with an International Guide for Tumor Classification. Springer Verlag, Tokyo, Japan, pp. 117-154.
18. Kimura, W., Morikane, K., Esaki, Y., Chan, W.C. and Pour, P.M. (1998) Histological and biological patterns of microscopical pancreatic ductal adenocarcinomaa detected incidentally at autopsy. Cancer, 82, 1839-1849.
19. Schmied, B., Liu, G., Matsuzaki, H., Hernberg, S., Moyer, M.P., Weide, L., Murphy, L., Batra, S.K. and Pour, P.M. (1999) Transformation of hamster pancreatic endocrine cells into exocrine cells. J. Cell. Sci., in press.
20. Ikematsu, Y., Liu, G., Fienhold, M.A., Cano, M., Adrian, T.E., Hollingsworth, M.A., Williamson, J.E., Sanger, W., Tomioka, T. and Pour, P.M. (1997) In vitro pancreatic ductal carcinogenesis. Int. J. Cancer, 72, 1095-1103.
21. Mangold, K.A., Mangino, M.M., Laconi, S. and Scarpelli, D.G. (1994) In vitro carcinogenesis of hamster pancreatic duct cells: cellular and molecular alterations. Carcinogenesis, 15, 1979-1984.
22. Takahashi, T, Moyer, M.P., Cano, M., Wang, Q.J., Mountjoy, C.P., Sanger, W., Adrian, T.E., Sugiura, H., Katoh, H. and Pour, P.M. (1995) Differences in molecular biological, biological and growth characteristics between the immortal and malignant hamster pancreatic ductal cells. Carcinogenesis, 16, 931-939.
23. Egami, H., Tomioka, T., Tempero, M. and Pour, P.M. (1991) Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamasters. Am. J. Pathol., 138, 557-561.
24. Pour, P.M., Kazakoff, K. and Dulany, K. (1993) A new multilabeling technique for simultaneous demonstration of different islet cells in permanent slides. Int. J. Pancreatol., 13, 139-142.
25. Fujii, H., Egami, H., Chaney, W., Pour, P.M. and Pelling, J. (1990) Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12, Mol. Carcinogen., 3, 296-301.
26. Takahashi, T., Moyer, M.P., Cano, M., Wang, Q.J., Adrian, T.E., Mountjoy, C.P., Sanger, W., Sugiura, H., Katoh, H. and Pour, P.M. (1995) Establishment and characterization of a new, spontaneously immortalized, pancreatic ductal cell line from the Syrian golden hamster. Cell Tissue Res., 282, 163-174.
27. Takahashi, T., Moyer, M.P., Cano, M., Wang, Q.J., Adrian, T.E., Mountjoy, C.P., Sanger, W., Sugiura, H., Katoh, H. and Pour, P.M. (1995) Establishment and characterization of a new, spotaneously immortalized, pancreatic ductal cell line from the Syrian golden hamster. Cell Tissue Res., 282, 163-174.
28. 3H]thymidine incorporation into DNA of rat esophageal epithelim and related tissues by carcinogenic N-nitroso compounds. Cancer Res., 38, 458-466.
29. Fujii, H., Inagaki, M., Kasai, S., Miyokawa, N., Tokusashi, Y., Gabrielson, E. and Hruban, R.H. (1997) Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am. J. Pancreatol., 151, 1447-1454.
30. Sugio, K., Molberg, K., Albores-Saavedra, J., Virmani, A.K., Kishimoto, Y. and Gazdar, A.F. (1997) K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers. Int. J. Pancreatol., 21, 205-217.
31. Hirota, M., Egami, H., Corra, S., Fujii, H., Chaney, W.G., Rizzino, A. and Pour, P.M. (1993) Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer cell line. Carcinogenesis, 14, 259-264.
32. Toshkov, I., Schmied, B., Adrian, T.E., Murphy, L.O., Wahab, H.A.A.Y. and Pour, P.M. (1998) Establishment of tumor cell line. 1LA, from hamster islets treated with BOP. Int. J. Cancer, 78, 636-641.
33. Korc, M., Chandasekar, B., Yamanaka, Y., Friess, H., Büchler,M. and Beger, H.G. (1992) Overexpression of the growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest., 90, 1352-1360.
34. Smith, J.J., Derynck, R. and Korc, R. (1987) Production of transforming growth factor a in human pancreatic cancer cells: evidence for a superagonistic autocrine cycle. Proc. Natl Acad. Sci. USA, 84, 7567-7570.
35. Screiber, A.B., Winkler, M.E. and Derynck, R. (1986) Transforming growth factor-ex: a more potent angiogenic mediator than epidermal growth factor. Science, 232, 1250-1253.
36. Yamaguchi, K., Morohoshi, T. and Zamboni, G. (1994) Solid cystic tumors. In Atlas of Exocrine Pancreatic Tumors. Morphology, Biology and Diagnosis with an International Guide for Tumor Classification. Springer Verlag. Tokyo, Japan, pp. 83-100.
37. Morohoshi, T., Kanda, M., Horie, A., Chotl, A., Dreyer, T., Klöppel, G. and Heitz, P.U. (1987) Immunohistochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma and solid cystic (papillary-cystic) tumor. Cancer, 59, 739-747.
38. Bouwens, L. and De Blay, E. (1996) Islet morphogenesis and stem cell markers in rat pancreas. J. Histochem. Cytochem., 44, 947-951.
39. Tanno, S., Obara, T., Shudo, R., Fujii, T., Sugawara, K., Nishino, N., Ura, H. and Kohgo, Y. (1997) α-Fetoprotein producing mucin-producing carcinoma of the pancreas. A case report with immunohistochemical study and lectin-affinity profile. Dig. Dis. Sci., 42, 2513-2518.
40. Hendrix, M.J.C., Seftor, E.A., Seftor, R.E.B. and Trevor, K.T. (1997) Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenolypic interconversion and increased invasive behavior. Am. J. Pathol., 150, 483-495.
41. Egami, H., Takiyama, Y., Cano, M., Houser, W.H. and Pour, P.M. (1989) Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. Carcinogenesis, 10, 861-869.
42. Pour, P.M., Uchida, E., Burnett, D.A. and Steplewski, Z. (1986) Blood-group antigen expression during pancreatic cancer induction in hamsters. Int. J. Pancreatol., 1, 327-340.
43. Bardi, G., Johansson, B., Pandis, N., Mandahl, N., Bak-Jensen, E., Andrén-Sandberg, Å., Mittelman, F. and Heim, S. (1993) Karyotypic abnormalities in tumors of the pancreas. Br. J. Cancer, 67, 1106-1112.
44. Johansson, B., Bardi, G., Heim, S., Mandahl, N., Mertens, F., Bak-Jensen, E., Andrén-Sandberg, Å. and Mittelman, F. (1992) Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer, 69, 1674-1681.
45. Bardi, G., Parada, L.A., Bomme, L., Pandis, N., Johansson, B., Willén, R., Fenger, C., Kronborg, O., Mittelman, F. and Heim, S. (1997) Cytogenetic findings in metastases from colorectal cancer. Int. J. Cancer, 72, 604-607.
46. Korc, M., Meltzer, P. and Trent, J. (1986) Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc. Natl Acad. Sci. USA, 83, 5141-5144.